Catalyst Wire Dossier Catalyst Wire Dossier

HLA-Haploidentical hematopoietic stem cell transplantation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLA-Haploidentical hematopoietic stem cell transplantation, covering 2013-01-03 to 2013-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia [Phase 1, Phase 2]

See pricing